Chennai Meenakshi Multispeciality Hospital Ltd.
BSE: 523489 | Sector: Health care |
NSE: N.A. | ISIN Code: INE889F01017 |
BSE 00:00 | 19 Aug | 22.00 |
0.30 (1.38%) |
OPEN
21.75 |
HIGH
22.00 |
LOW
21.50 |
NSE 05:30 | 01 Jan | Chennai Meenakshi Multispeciality Hospital Ltd |
OPEN | 21.75 |
PREVIOUS CLOSE | 21.70 |
VOLUME | 4434 |
52-Week high | 31.40 |
52-Week low | 15.60 |
P/E | |
Mkt Cap.(Rs cr) | 16 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Chennai Meenakshi Multispeciality Hospital Ltd. (CHENNAIMEENA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 900.30 | -15.45 | -1.69 | 15585.98 |
Dr Reddy's Labs | 4199.95 | -25.60 | -0.61 | 14405.20 |
Cipla | 1030.35 | -1.75 | -0.17 | 13091.79 |
Lupin | 689.00 | 0.50 | 0.07 | 11771.67 |
Aurobindo Pharma | 569.40 | -13.55 | -2.32 | 11287.14 |
Divi's Lab. | 3696.05 | -48.35 | -1.29 | 8879.82 |
Alkem Lab | 2937.90 | 10.35 | 0.35 | 8829.81 |
Zydus Lifesci. | 387.65 | -6.45 | -1.64 | 7981.90 |
Glenmark Pharma. | 387.15 | -12.45 | -3.12 | 7567.93 |
Torrent Pharma. | 1541.85 | -18.40 | -1.18 | 6742.32 |
Apollo Hospitals | 4136.85 | -133.70 | -3.13 | 6098.30 |
Ipca Labs. | 919.00 | -6.00 | -0.65 | 5399.36 |
Alembic Pharma | 651.85 | -2.85 | -0.44 | 5051.44 |
Abbott India | 18845.75 | -166.25 | -0.87 | 4919.27 |
Laurus Labs | 581.80 | -8.45 | -1.43 | 4707.04 |
Gland Pharma | 2411.90 | 12.80 | 0.53 | 4400.71 |
Granules India | 312.65 | -12.60 | -3.87 | 3238.44 |
Glaxosmi. Pharma | 1473.40 | -5.20 | -0.35 | 3217.51 |
Ajanta Pharma | 1294.65 | 36.00 | 2.86 | 3140.64 |
Sanofi India | 6336.45 | -38.55 | -0.60 | 2956.60 |
Quick Links for Chennai Meenakshi Multispeciality Hospital:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices